JOURNAL ARTICLE

Efficacy and safety of labetalol vs. Hydralazine in pregnant women with severe hypertension.

  • Published In: Pulse International, 2026, v. 27, n. 2. P. N.PAG 1 of 2

  • Database: Academic Search Ultimate 2 of 2

Abstract

The study evaluates the effectiveness of labetalol compared to hydralazine in managing severe hypertension during pregnancy. Conducted at the Department of Gynecology, Services Hospital Lahore, the quasi-experimental study involved 320 pregnant women diagnosed with severe hypertension, divided into two treatment groups. Results indicated that labetalol achieved target blood pressure in 83.8% of participants, while hydralazine achieved it in 71.2%, with hydralazine providing faster blood pressure control but with more adverse effects. The study concludes that labetalol is preferable for sustained blood pressure management, whereas hydralazine is more effective for rapid blood pressure reduction. [Extracted from the article]

Additional Information

  • Source:Pulse International. 2026/01, Vol. 27, Issue 2, pN.PAG
  • Document Type:Article
  • Subject Area:Health and Medicine
  • Publication Date:2026
  • ISSN:1682-0274
  • Accession Number:191179774
  • Copyright Statement:Copyright of Pulse International is the property of Knowledge Bylanes and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.